Clinical Trial Detail

NCT ID NCT02791919
Title Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

acute myeloid leukemia

Therapies

Adavosertib

Cytarabine + Filgrastim + Fludarabine

Age Groups: adult child

No variant requirements are available.